Middle east respiratory syndrome coronavirus from discovery to intervention in the Middle East region : a review

Abstract EN

-Middle East Respiratory Syndrome Coronavirus (MERS-CoV) which belongs to the family of coronavirus causes Middle East Respiratory Syndrome (MERS).

Most of the patients, who got infected with MERS, develop a serious respiratory illness.

Numerous viral epidemics have surfaced in different biological regions in the last two decades.

COVID-19 which began in the second half of December 2019 as a novel pandemic outbreak, is due to a new strain of coronavirus, as categorization of genes could not match the earlier coronavirus strains.

This new strain had been labeled as 2019-nCoV or Cov 2 and is classified under severe acute respiratory distress syndrome.

This new strain has a very high rate of spread through the droplet infection and it is transmissible.

The serious and dangerous infections which require ICU admission and ventilation.

Five percent (5%) of patients who require oxygen are considered to have a serious infection and makeup fifteen percent (15%) of total patients infected.

Whereas, eighty percent (80%) of the infected patients have no or mild symptoms.

This study explores the journey of this virus from its origin many years ago in the Middle East; though it was known with unique names and now seems to be emerging as a new strain due to an unusual genome under the name of COVID -19.